• Return to Headlines

Shares of Merck & Co Has Risen Above Previous 52-Week High

By Nick Russo

Merck & Co (NYSE:MRK) traded at a new 52-week high today of $86.38. Approximately 1.3 million shares have changed hands today, as compared to an average 30-day volume of 8.6 million shares.

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.

Based on a current price of $86.38, Merck & Co is currently 19.7% above its average consensus analyst price target of $69.33. The stock should discover initial support at its 50-day moving average (MA) of $79.42 and subsequent support at its 200-day MA of $76.53.

In the past 52 weeks, shares of Merck & Co have traded between a low of $59.80 and a high of $86.38 and are now at $86.38, which is 44% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has risen 0.3%.

SmarTrend recommended that subscribers consider buying shares of Merck & Co on May 1st, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $79.08. Since that recommendation, shares of Merck & Co have risen 7.9%. We continue to monitor MRK for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows Merck & Co

Ticker(s): MRK